Max Healthcare Institute Ltd (MAXHEALTH) Q4FY25 Concall Summary - Mar-2025 Qtr
Performance Overview
- Max Healthcare demonstrated strong financial performance in FY25, driven by strategic acquisitions and organic growth initiatives. Revenue grew by 26% year-on-year, reaching INR 9,065 crore, while EBITDA increased by 22% to INR 2,319 crore.
- Newly acquired hospitals, Max Lucknow and Max Nagpur, contributed significantly to the top-line and EBITDA growth. Max Lucknow achieved a remarkable 56% revenue growth and 102% EBITDA growth, while Max Nagpur reported 23% and 86% growth in revenue and EBITDA, respectively.
- The asset-light hospital in Dwarka achieved EBITDA breakeven within six months of operation, generating INR 171 crore in revenue for FY25.
- Max Healthcare continued its expansion strategy, commissioning brownfield towers at Max Smart, Nanavati-Max, and Max Mohali, and completing a greenfield facility in Gurgaon, adding approximately 1,500 beds.
- The company received recognition for its corporate governance practices, ranking among the Top 20 companies in the S&P BSE 100 Index and being recognized under the "Next Leaders" category by IiAS.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.